Eagle Rock Investment Company »

Corcept Therapeutics Incorporated shares owned by Eagle Rock Investment Company

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Eagle Rock Investment Company from 13F filings

Historical chart of Eagle Rock Investment Company investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Eagle Rock Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Eagle Rock Investment Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $395k 4.8k 83.11
2025-06-30 $294k 4.0k 73.40
2025-03-31 $343k 3.0k 114.22

More positions owned by Eagle Rock Investment Company

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
AutoZone (AZO)
Chubb (CB)
Kla Corp Com New (KLAC)
American Express Company (AXP)
Visa Com Cl A (V)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Cbre Group Cl A (CBRE)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)

View all positions for Eagle Rock Investment Company

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated